Target intelligence / Profile preview

Aristaless-related homeobox protein (ARX)

Target
ARX
Molecular classification
Transcription factor, Homeobox protein, DNA-binding protein
01

Overview

Aristaless-related homeobox protein (ARX) is a transcription factor encoded by the ARX gene on the X chromosome. It is a member of the homeobox gene family and contains conserved domains including a paired-like homeodomain and an aristaless domain. ARX is crucial for embryonic development, especially of the brain, pancreas, testes, and skeletal muscles. Its primary molecular function is as a DNA-binding transcriptional repressor, acting on genes involved in neuronal migration, differentiation, and proliferation. ARX binds to a core “TAAT” sequence within promoter regions and can act through protein-protein interactions involving Groucho and CtBP co-repressors[1][2][3][5]. Mutations in ARX, both point and polyalanine repeat expansions, are associated with a broad spectrum of neurodevelopmental disorders (X-linked intellectual disability, lissencephaly, infantile epileptic encephalopathy, Partington syndrome), often involving severe brain malformations, epilepsy, and endocrine defects[1][3][5]. ARX is thus considered a critical therapeutic and diagnostic target for congenital brain disorders, epilepsy, and intellectual disabilities.

Other names
Homeobox protein ARXISSXCT121EIEE1cancer/testis antigen 121MRX29MRX32MRX33MRX36MRX38MRX43MRX54MRX76MRX87MRXS1PRTS
02

Biological functions

Regulation of gene transcriptionNeuronal differentiation and migrationCell proliferationCell differentiation (pancreas, testes, skeletal muscle)Embryonic developmentTranscriptional repression and activation
03

Disease associations

Neurodevelopmental disorders (including X-linked intellectual disability, lissencephaly, developmental and epileptic encephalopathy, Partington syndrome, Proud syndrome, hydranencephaly)Epilepsy (infantile spasms)Abnormal brain and genital developmentIntellectual disabilityOther developmental malformations
04

Safety considerations

Highly pleiotropic functions affect brain, pancreas, testes, and muscle; mutations cause profound neurodevelopmental and endocrine abnormalities with severe clinical outcomes.Challenges include unpredictability of phenotype based on mutation type and widespread effects due to developmental expression.
05

Biomarkers

Mutations/expansions in ARX (especially polyalanine repeat expansions, homeodomain point mutations) can serve as biomarkers for several diseases: DEE1, XLAG, Partington syndrome, Proud syndrome

Beyond the preview

Go deeper on Aristaless-related homeobox protein (ARX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aristaless-related homeobox protein (ARX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call